Prolongation of liver xenograft survival by adenovirus vector-mediated CTLA-4Ig gene transfer.

[1]  H. Hamada,et al.  Adenovirus-mediated gene therapy for mucopolysaccharidosis VII: involvement of cross-correction in wide-spread distribution of the gene products and long-term effects of CTLA-4Ig coexpression. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  D. Sachs,et al.  Blockade of CD28-B7, But Not CD40-CD154, Prevents Costimulation of Allogeneic Porcine and Xenogeneic Human Anti-Porcine T Cell Responses1 , 2000, The Journal of Immunology.

[3]  S. Enosawa,et al.  Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4Ig-gene. , 1999, Transplantation.

[4]  P. Loth,et al.  Prolongation of heart xenograft survival in a hamster-to-rat model after therapy with a rationally designed immunosuppressive peptide. , 1999, Transplantation.

[5]  S. Bonner-Weir,et al.  Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig. , 1999, Transplantation.

[6]  I. Clarke,et al.  T cells are necessary and critical for xenograft rejection in new concordant cardiac xenotransplant model. , 1999, Transplantation.

[7]  J. Contreras,et al.  Genetic modification of liver grafts with an adenoviral vector encoding the Bcl-2 gene improves organ preservation. , 1999, Transplantation.

[8]  M. Diefenbeck,et al.  Intravital microscopic investigation of xenogeneic microcirculation and impact of complement depletion by cobra venom factor , 1998, Xenotransplantation.

[9]  F. Bach,et al.  Survival of accommodated cardiac xenografts upon retransplantation into cyclosporine-treated recipients. , 1998, Transplantation.

[10]  M. Sayegh,et al.  Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen. , 1998, Journal of the American Society of Nephrology : JASN.

[11]  M. Waer,et al.  Contribution of activated macrophages to the process of delayed xenograft rejection. , 1997, Transplantation.

[12]  P. Linsley,et al.  The role of donor and recipient B7-1 (CD80) in allograft rejection. , 1997, Journal of immunology.

[13]  M. Waer,et al.  Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. , 1997, Journal of immunology.

[14]  J. Allison,et al.  Co-stimulation in T cell responses. , 1997, Current opinion in immunology.

[15]  J. Trapani,et al.  Xenospecific cytotoxic T lymphocytes use perforin- and Fas-mediated lytic pathways. , 1996, Transplantation.

[16]  P. Linsley,et al.  Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion. , 1996, Surgery.

[17]  T. Loudovaris,et al.  CD4+ T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+ T cells and B cells. , 1996, Transplantation.

[18]  W. Baldwin,et al.  CTLA4Ig Inhibits humoral and cellular immune responses to concordant xenografts. , 1996, Transplantation proceedings.

[19]  Y. Kanegae,et al.  Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  G. Freeman,et al.  Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. , 1995, Transplantation.

[21]  A. Gown,et al.  Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administration , 1995, Nature Genetics.

[22]  J. Bluestone.  New perspectives of C1328-137-mediated T cell costimulation , 1995 .

[23]  C. Morris,et al.  Intragraft expression of cytokine transcripts during pig proislet xenograft rejection and tolerance in mice. , 1995, Journal of immunology.

[24]  N. Sarvetnick,et al.  Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Yaozhong Ding,et al.  Gene Transfer for Transplantation Prolongation of Allograft Survival with Transforming Growth Factor-β1 , 1994, Annals of surgery.

[26]  P. Linsley,et al.  Transplantation tolerance induced by CTLA4-Ig. , 1994, Transplantation.

[27]  T. Starzl,et al.  DONOR SPECIES COMPLEMENT AFTER LIVER XENOTRANSPLANTATION: THE MECHANISM OF PROTECTION FROM HYPERACUTE REJECTION1,2 , 1994, Transplantation.

[28]  A. Demetris,et al.  Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. , 1993, The American journal of pathology.

[29]  A. Demetris,et al.  Long-term survival of heart and liver xenografts with splenectomy and FK 506. , 1993, Transplantation proceedings.

[30]  D. Cooper.  Is xenotransplantation a realistic clinical option? , 1992, Transplantation proceedings.

[31]  P. Linsley,et al.  Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. , 1992, Science.

[32]  S. Thorgeirsson,et al.  Adenovirus–mediated in vivo gene transfer and expression in normal rat liver , 1992, Nature Genetics.

[33]  P. Linsley,et al.  CTLA-4 is a second receptor for the B cell activation antigen B7 , 1991, The Journal of experimental medicine.

[34]  F. Bach,et al.  Immunology of xenograft rejection. , 1990, Human immunology.

[35]  R. Pierson,et al.  Xenogeneic skin graft rejection is especially dependent on CD4+ T cells , 1989, The Journal of experimental medicine.

[36]  F. Graham,et al.  Use of human adenovirus-based vectors for antigen expression in animals. , 1989, The Journal of general virology.

[37]  M. Monden,et al.  HAMSTER‐TO‐RAT ORTHOTOPIC LIVER XENOGRAFTS , 1987, Transplantation.

[38]  M. Monden,et al.  Hepatic xenografts from hamster to rat. , 1987, Transplantation proceedings.

[39]  J. Adams.  Heavy metal intensification of DAB-based HRP reaction product. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[40]  T. Starzl,et al.  DONOR SPECIES COMPLEMENT AFTER LIVER XENOTRANSPLANTATION , 1994 .

[41]  A. Demetris,et al.  Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection. , 1994, Transplantation proceedings.

[42]  R. Calne,et al.  A surgical experience with five hundred thirty liver transplants in the rat. , 1983, Surgery.